The Journal of Korean Obstetrics and Gynecology (대한한방부인과학회지)

The Society of Korean Medicine Obstetrics and Gynecology (대한한방부인과학회)
권호 표지
DOI QR코드

DOI QR Code

Anti-osteoporotic Activity of Gojineumja Aqueous Extracts on the Ovariectomized Mice

난소적출 마우스에서 고진음자(固眞飮子) 물 추출물의 골다공증 개선 효과

  • Cho, Su-Yun (Dept. of Korean Obstetrics & Gynecology, College of Korean Medicine, Daegu Haany University) ;
  • Kim, Dong-Chul (Dept. of Korean Obstetrics & Gynecology, College of Korean Medicine, Daegu Haany University)
  • 조수연 (대구한의대학교 한의과대학 부인과학교실) ;
  • 김동철 (대구한의대학교 한의과대학 부인과학교실)
  • Received : 2018.09.19
  • Accepted : 2018.11.26
  • Published : 2018.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: The objective of this in vivo study is to observe the anti-osteoporotic activities of Gojineumja aqueous extracts (GJEJ) on the ovariectomized (OVX) mice as compared to those of risedronate sodium (RES). Methods: Thirty five days after bilateral OVX, GJEJ was orally administered, for 35 days once a day and then the changes on the body weight and gain during experimental periods, femur weights, bone mineral density (BMD), bone strength (failure load), mineral contents - calcium (Ca) and inorganic phosphorus (IP), histological profiles and histomorphometrical analyses at sacrifice were conducted with serum biochemistry - osteocalcin contents and bone specific alkaline phosphatase (BALP) activities. And the results of GJEJ were compared with RES orally administered OVX mice. Results: As a result of OVX, noticeable increase of body weight and gains and serum osteocalcin levels, decrease of serum BALP activities, femur weights, femur Ca and IP contents, BMD and strength were observed as compared to those of sham control mice, respectively. Also, the decrease of all histomorphometrical indices indicating the bone mass and structure, and the increase of indices about resorption were also detected in the femur of OVX control. However, these estrogen-deficient osteoporotic signs were significantly and dose-dependently inhibited by 35 days of continuous oral treatment of GJEJ, at dose levels of 500, 250 and 125 mg/kg, respectively. Especially, GJEJ 500 mg/kg showed favorable inhibitory activities against estrogen-deficient osteoporosis symptoms induced by OVX as comparable to those of RES 2.5 mg/kg. Conclusions: The results in this study suggest that oral administrations of GJEJ have clear dose-dependent favorable anti-osteoporotic activities in OVX mice.

목 적: 본 연구에서는 고진음자 물 추출물의 골다공증 개선 효과를 난소적출 마우스를 이용하여 risedronate sodium(RES) 2.5 mg/kg 투여군과 비교 평가하였다. 방 법: OVX 35일 후부터 고진음자 물 추출물을 매일 1회씩 35일간 연속 경구 투여하고, 체중, 대퇴골의 중량, 골밀도, 골강도, 무기질 - 칼슘(Ca) 및 무기인(inorganic phosphorus, IP) 함량, 골량 및 구조와 골흡수에 관한 조직병리학적 변화를 혈중 osteocalcin 함량 및 bone specific alkaline phosphatase(BALP) 활성의 변화와 함께 각각 측정하였다. 본 실험에서 고진음자 물 추출물에서의 결과는 RES 경구 투여 OVX 마우스에서의 결과와 비교 평가 하였다. 결 과: OVX대조군에서는 현저한 체중 증가와 함께 대퇴골의 중량, 골밀도, 골강도, 무기질 - Ca 및 IP 함량 감소 및 지주골과 피질골의 현저한 조직병리학적 감소가 함께 확인되었으며, 혈중 osteocalcin 함량의 증가와 함께 혈중 BALP 활성의 감소가 각각 확인되었다. 이에, 전형적인 estrogen 결핍성 골다공증 소견이 OVX 수술에 의해 유발되는 것으로 관찰되었다. 한편 이렇게 OVX에 의해 유발된 estrogen 결핍성 골다공증 소견이 모든 세 용량의 고진음자 물 추출물 500, 250 및 125 mg/kg의 35일에 걸친 연속 경구 투여에 의해 투여 용량 의존적으로 현저히 억제되었고, 특히 고진음자 물 추출물 500 mg/kg은 RES 2.5 mg/kg 투여군과 비교할 만한 골다공증 개선 효과를 나타내었다. 결 론: 이상의 결과에서, 고진음자 물 추출물은 난소적출 마우스에서 투여 용량 의존적으로 유효한 골다공증 개선 효과를 나타내는 것으로 관찰되었다. 따라서 적절한 용량의 고진음자 물 추출물은 새로운 보다 효과적인 estrogen 결핍성 골다공증 개선제로서의 개발 가능성이 매우 높을 것으로 기대된다. 한편 고진음자는 15종의 약제로 구성되어 있으며, 각각의 개별 약제는 수많은 생리활성 물질을 함유하고 있어, 앞으로 생리활성을 나타내는 화학성분의 검색과 함께 다양한 방면으로 기전연구가 추가적으로 수행되어야 할 것으로 판단된다.

Keywords

References

  1. Korean Society of Obstetrics and Gynecology. Gynecology, 5th ed. Seoul:Korea Medical Publishing Company. 2015:659-61.
  2. The Korean Association of Internal Medicine. Harrison's Internal Medicine, 17th ed. Seoul:MIP publication. 2010:2883-95.
  3. Yamaguchi K, et al. Suppressive effect of norzoanthamine hydrochloride on experimental osteoporosis in ovariectomized mice. Biol Pharm Bull. 1999;22(9):920-4. https://doi.org/10.1248/bpb.22.920
  4. Kang SG, Park YB, Ahn HS. The Bibliographical Studies on the Acupuncture Treatment of the Osteoporosis. K.A.M.S. 1995;15(2):171-90.
  5. Kim HJ, Lee TG. Literature Review of Menopausal osteoporosis. J Korean Obstet Gynecol. 1998;11(1):131-48.
  6. Lee C. Introduction to Medicine(醫學入門). Seoul:Bubin Publisher. 2009:1892.
  7. Huh J. Dongeuibogam(東醫寶鑑). Seoul: Namsandang. 1966:447.
  8. Kang DW, Kang SB. Effects of Gojineumja on immunosuppression induced by methotrexate in rat. Korean J Orient Int Med. 2004;25(4):117-28.
  9. Kim HJ, Jung IC, Lee SR. Effect of Gojineumja(Guzhenyinzi) on neural tissue degeneration in mouse model of Alzheimer disease. J Oriental Neuropsychiatry. 2009;20(2):31-46.
  10. Won CH, et al. Effect of Kojinyumja on galactosamine induced hepatotoxicity in rats. Dongguk J the Institute of Oriental Medicine. 1997;6(1):137-49.
  11. Lim DW, Kim YT. Dried root of Rehmannia glutinosa prevents bone loss in ovariectomized rats. Molecules. 2013;18(5):5804-13. https://doi.org/10.3390/molecules18055804
  12. Han N, et al. The in vivo effects of a fraction from Dioscorea spongiosa on glucocorticoid-induced osteoporosis. J Ethnopharmacol. 2016;185:53-9. https://doi.org/10.1016/j.jep.2016.03.033
  13. Shin HD, et al. Antiosteoporotic effect of Polycan, beta-glucan from Aureobasidium, in ovariectomized osteoporotic mice. Nutrition. 2007;23(11-12):853-60. https://doi.org/10.1016/j.nut.2007.08.011
  14. Joo JH, et al. A novel pyrazole derivative protects from ovariectomyinduced osteoporosis through the inhibition of NADPH oxidase. Sci Rep. 2016;6:22389. https://doi.org/10.1038/srep22389
  15. Kang SJ, et al. Selection of the optimal herbal compositions of red clover and pomegranate according to their protective effect against climacteric symptoms in ovariectomized mice. Nutrients. 2016;8(8):447. https://doi.org/10.3390/nu8080447
  16. Harris ST, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA. 1999;282(14):1344-52. https://doi.org/10.1001/jama.282.14.1344
  17. Nam SH, et al. Topically administered Risedronate shows powerful anti-osteoporosis effect in ovariectomized mouse model. Bone. 2012;50(1):149-55. https://doi.org/10.1016/j.bone.2011.10.017
  18. Kang SJ, et al. Fermentation with Aquilariae Lignum enhances the antidiabetic activity of green tea in type II diabetic db/db mouse. Nutrients. 2014;6(9):3536-71. https://doi.org/10.3390/nu6093536
  19. Choi JS, et al. Blood glycemia-modulating effects of melanian snail protein hydrolysates in mice with type II diabetes. Int J Mol Med. 2017;39(6):1437-51. https://doi.org/10.3892/ijmm.2017.2967
  20. Manolagas SC, Kousteni S, Jilka RL. Sex steroids and bone. Recent Prog Horm Res. 2002;57:385-409. https://doi.org/10.1210/rp.57.1.385
  21. Melton LJ 3rd, et al. How many women have osteoporosis? J Bone Miner Res. 2005;20(5):886-92. https://doi.org/10.1359/jbmr.2005.20.5.886
  22. Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science. 2000;289(5484):1508-14. https://doi.org/10.1126/science.289.5484.1508
  23. Gowen M, Emery JG, Kumar S. Emerging therapies for osteoporosis. Emerging Drugs. 2000;5:1-43. https://doi.org/10.1517/14728214.5.1.1
  24. Devipriya N, et al. Effect of ellagic acid, a natural polyphenol, on alcoholinduced prooxidant and antioxidant imbalance: a drug dose dependent study. Singapore Med J. 2007;48(4):311-8.
  25. Kim HS, et al. Single oral dose toxicity test of blue honeysuckle concentrate in mice. Toxicol Res. 2015;31(1):61-8. https://doi.org/10.5487/TR.2015.31.1.061
  26. Noh JR, et al. Hepatoprotective effect of Platycodon grandiflorum against chronic ethanolinduced oxidative stress in C57BL/6 mice. Ann Nutr Metab. 2011;58(3):224-31. https://doi.org/10.1159/000330117
  27. Editing commission of herbal medicine. Bon-Cho-Hak(本草學). 2nd rev. ed. Seoul:Yeong-Rim-Sa. 2011:581, 603-4, 607-8, 633-4, 681, 688.
  28. Cho CY, et al. Effects of Bia-hwan (Feier-wan) on the Ovariectomized Rat Model of Osteoporosis. Journal of Korean Medicine Rehabilitation. 2017;27(2):19-27. https://doi.org/10.18325/JKMR.2017.27.2.19
  29. Kim JH, et al. Effects of Cuscutae Semen Extract on Prevention of Osteoporosis in Ovariectomized Rats. J Korean Obstet Gynecol. 2012;25(4):1-11. https://doi.org/10.15204/JKOBGY.2012.25.4.001
  30. Boonen S, et al. Preventing osteoporotic fractures with antiresorptive therapy: implications of microarchitectural changes. J Intern Med. 2004;255(1):1-12. https://doi.org/10.1046/j.0954-6820.2003.01258.x
  31. Bae DC, Stein BS. The diagnosis and treatment of osteoporosis in men on androgen deprivation therapy for advanced carcinoma of the prostate. J Urol. 2004;172(6 Pt 1):2137-44. https://doi.org/10.1097/01.ju.0000141515.67372.e5
  32. Roux C, et al. Efficacy of risedronate on clinical vertebral fractures within six months. Curr Med Res Opin. 2004;20(4):433-9. https://doi.org/10.1185/030079903125003125
  33. Ito M, et al. Effects of risedronate on trabecular microstructure and biomechanical properties in ovariectomized rat tibia. Osteoporos Int. 2005;16(9):1042-8. https://doi.org/10.1007/s00198-004-1802-3
  34. Lorden JF, Caudle A. Behavioral and endocrinological effects of single injections of monosodium glutamate in the mouse. Neurobehav Toxicol Teratol. 1986;8(5):509-19.
  35. Bain SD, et al. High-dose estrogen inhibits bone resorption and stimulates bone formation in the ovariectomized mouse. J Bone Miner Res. 1993;8(4):435-42. https://doi.org/10.1002/jbmr.5650080407
  36. Sandstedt J, et al. Elevated levels of growth hormone increase bone mineral content in normal young mice, but not in ovariectomized mice. Endocrinology. 1996;137(8):3368-74. https://doi.org/10.1210/endo.137.8.8754763
  37. Andersson N, et al. Repeated in vivo determinations of bone mineral density during parathyroid hormone treatment in ovariectomized mice. J Endocrinol. 2001;170(3):529-37. https://doi.org/10.1677/joe.0.1700529
  38. Yamamoto M, et al. The integrin ligand echistatin prevents bone loss in ovariectomized mice and rats. Endocrinology. 1998;139(3):1411-9. https://doi.org/10.1210/endo.139.3.5831
  39. Ederveen AG, Kloosterboer HJ. Tibolone, a steroid with a tissue-specific hormonal profile, completely prevents ovariectomyinduced bone loss in sexually mature rats. J Bone Miner Res. 1999;14(11):1963-70. https://doi.org/10.1359/jbmr.1999.14.11.1963
  40. Ke HZ, et al. Long-term treatment of lasofoxifene preserves bone mass and bone strength and dose not adversely affect the uterus in ovariectomized rats. Endocrinology. 2004;145(4):1996-2005. https://doi.org/10.1210/en.2003-1481
  41. Syed Z, Khan A. Bone densitometry: applications and limitations. J Obstet Gynaecol Can. 2002;24(6):476-84. https://doi.org/10.1016/S1701-2163(16)31095-7
  42. Diez F. Guidelines for the diagnosis of osteoporosis by densitometric methods. J Manipulative Physiol Ther. 2002;25(6):403-15. https://doi.org/10.1067/mmt.2001.126126
  43. Tarvainen R, et al. Clodronate prevents immobilization osteopenia in rats. Acta Orthop Scand. 1994;65(6):643-6. https://doi.org/10.3109/17453679408994622
  44. Tanaka S, et al. Acute effects of ovariectomy on wound healing of alveolar bone after maxillary molar extraction in aged rats. Anat Rec. 2001;262(2):203-12. https://doi.org/10.1002/1097-0185(20010201)262:2<203::AID-AR1030>3.0.CO;2-#
  45. Heikkinen T, Puolivali J, Tanila H. Effects of long-term ovariectomy and estrogen treatment on maze learning in aged mice. Exp Gerontol. 2004;39(9) :1277-83. https://doi.org/10.1016/j.exger.2004.05.005
  46. Jakubas-Przewlocka J, Przewlocki P, Sawicki A. Assessment of changes due to the long-term effect of estrogen and calcium deficiency in the trabecular bone structure in rats. Clin Exp Rheumatol. 2005;23(3):385-8.
  47. Murakami H, et al. Effects of tiludronate on bone mass, structure, and turnover at the epiphyseal, primary, and secondary spongiosa in the proximal tibia of growing rats after sciatic neurectomy. J Bone Miner Res. 1994;9(9):1355-64. https://doi.org/10.1002/jbmr.5650090906
  48. Weinreb M, et al. Short-term healing kinetics of cortical and cancellous bone osteopenia induced by unloading during the reloading period in young rats. Virchows Arch. 1997;431(6):449-52. https://doi.org/10.1007/s004280050122

Cited by

  1. 수컷 생쥐의 골다공증과 근위축에 대한 익지인(益智仁)의 효과 vol.40, pp.1, 2018, https://doi.org/10.22246/jikm.2019.40.1.1
  2. 골다공증의 한약 치료 효과: 국내 및 국외 동물 실험 및 임상 연구 논문에 대한 문헌 고찰 vol.31, pp.3, 2021, https://doi.org/10.18325/jkmr.2021.31.3.31